The parental burden of care of children with rare diseases is considerable and deserves due attention and support.
Undiagnosed or misdiagnosed hereditary angioedema exacts a heavy burden on patients due to missed opportunities for treatment.
Although common, gastrointestinal symptoms in hereditary angioedema are often misdiagnosed, leading to unnecessary investigational procedures.
A chief goal of HAE therapy is to achieve long attack-free periods that allow patients to live their lives with a measure of certainty.
Research suggests mental health issues due to concerns about the COVID-19 pandemic can exacerbate symptoms of hereditary angioedema.
It is vital that physicians and their patients are on the same page with regard to hereditary angioedema care.
Our understanding of the pathophysiological mechanisms underpinning hereditary angioedema has improved drastically over the last few years.
The difficulty in diagnosing hereditary angioedema lies in the variability of its phenotype. An initial misdiagnosis is not uncommon.